Zerityph Inj.
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- Category
- Veterinary Medicine
Boryung Pharmaceutical Co., Ltd.
- Country / Year Established
-
South Korea
/
1957
- Business type
- Manufacturer
- Verified Certificate
-
16
| Product name | Zerityph Inj. | Certification | - |
|---|---|---|---|
| Category | Veterinary Medicine | Ingredients | - |
| Keyword | - | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | Stock | - | |
| Supply type | - | HS code | - |
Product Information
Active Ingredient
0.5ml: 0.025mg of purified typhoid Vi antigen polysaccharide powder
Indication
Prevention of typhoid fever
Dosage and Administration
Adults and children over 5 years : one time intramusculac or subcutaneous injection 0.5ml/dose
Package
0.5ml× 10 vials
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
- President
- KIM KWANG HO
- Address
- Boryung Bldg., 66-21 Wonnam-dong, , Chongro-guSeoul,
- Product Category
- Computer & Information Technology Service
- Year Established
- 1957
- No. of Total Employees
- over 2000
- Company introduction
-
We, Boryung Pharm. has been dedicated to manufacturing and exporting since our establishment, 1963, specializing in Anticanger drug, Antibiotics, Anti-hypertension agent, Anti-ulcer drug, etc. We are also able to suppy quality vaccines, skin care items and baby products, representing our affiliated companies, Boryung Biopharm. & Boryung Medience.
- Main Markets
-
China
Indonesia
Japan
Nigeria
Thailand
- Main Product
Related Products
Portable Xray Unit / Xsima PO60
Naftalofos
Drug, medicine, API, pharmaceutical raw material, surgical dressing
CaniShot DHPPL
CaniShot PC
